119 related articles for article (PubMed ID: 32519340)
21. Preparation of Self-Assembled, Curcumin-Loaded Nano-Micelles Using Quarternized Chitosan-Vanillin Imine (QCS-Vani Imine) Conjugate and Evaluation of Synergistic Anticancer Effect with Cisplatin.
Sripetthong S; Nalinbenjapun S; Basit A; Surassmo S; Sajomsang W; Ovatlarnporn C
J Funct Biomater; 2023 Oct; 14(10):. PubMed ID: 37888190
[TBL] [Abstract][Full Text] [Related]
22. Supramolecular Biomaterials for Cancer Immunotherapy.
Liang H; Lu Q; Yang J; Yu G
Research (Wash D C); 2023; 6():0211. PubMed ID: 37705962
[TBL] [Abstract][Full Text] [Related]
23. A Cross-Talk about Radioresistance in Lung Cancer-How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies.
Nowak P; Bil-Lula I; Śliwińska-Mossoń M
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446385
[TBL] [Abstract][Full Text] [Related]
24. The evaluation of chitosan hydrogel based curcumin effect on DNMT1, DNMT3A, DNMT3B, MEG3, HOTAIR gene expression in glioblastoma cell line.
Abolfathi S; Zare M
Mol Biol Rep; 2023 Jul; 50(7):5977-5989. PubMed ID: 37268862
[TBL] [Abstract][Full Text] [Related]
25. Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance.
Hashemi M; Sabouni E; Rahmanian P; Entezari M; Mojtabavi M; Raei B; Zandieh MA; Behroozaghdam M; Mirzaei S; Hushmandi K; Nabavi N; Salimimoghadam S; Ren J; Rashidi M; Raesi R; Taheriazam A; Alexiou A; Papadakis M; Tan SC
Cell Mol Biol Lett; 2023 Apr; 28(1):33. PubMed ID: 37085753
[TBL] [Abstract][Full Text] [Related]
26. Intrinsic Permeation and Anti-Inflammatory Evaluation of Curcumin, Bisdemethoxycurcumin and Bisdemethylcurcumin by a Validated HPLC-UV Method.
Alvarado HL; Limón D; Calpena-Campmany AC; Mallandrich M; Rodríguez-Cid L; Aliaga-Alcalde N; González-Campo A; Pérez-García L
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047613
[TBL] [Abstract][Full Text] [Related]
27. Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing.
Rajasegaran T; How CW; Saud A; Ali A; Lim JCW
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986550
[TBL] [Abstract][Full Text] [Related]
28. Cyclovirobuxine D inhibits growth and progression of non‑small cell lung cancer cells by suppressing the KIF11‑CDC25C‑CDK1‑CyclinB1 G
Xue T; Chen Y; Xu J; Du W; Kong P; Zhang X
Int J Oncol; 2023 May; 62(5):. PubMed ID: 36929198
[TBL] [Abstract][Full Text] [Related]
29. A novel class of C14-sulfonate-tetrandrine derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
Jiang T; Xie G; Zeng Z; Lan J; Liu H; Li J; Ren H; Chen T; Pan W
Front Chem; 2022; 10():1107824. PubMed ID: 36704617
[TBL] [Abstract][Full Text] [Related]
30. Targeting lncRNAs of colorectal cancers with natural products.
Sung WJ; Hong J
Front Pharmacol; 2022; 13():1050032. PubMed ID: 36699052
[TBL] [Abstract][Full Text] [Related]
31. Curcumin Induces Ferroptosis in Follicular Thyroid Cancer by Upregulating HO-1 Expression.
Chen H; Li Z; Xu J; Zhang N; Chen J; Wang G; Zhao Y
Oxid Med Cell Longev; 2023; 2023():6896790. PubMed ID: 36691638
[TBL] [Abstract][Full Text] [Related]
32. Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1.
Zhu J; Cao K; Zhao M; Ma K; Jiang X; Bai Y; Ling X; Ma J
Mol Med; 2023 Jan; 29(1):6. PubMed ID: 36647009
[TBL] [Abstract][Full Text] [Related]
33. Strategies for Improving Bioavailability, Bioactivity, and Physical-Chemical Behavior of Curcumin.
Racz LZ; Racz CP; Pop LC; Tomoaia G; Mocanu A; Barbu I; Sárközi M; Roman I; Avram A; Tomoaia-Cotisel M; Toma VA
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296447
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action.
Behroozaghdam M; Dehghani M; Zabolian A; Kamali D; Javanshir S; Hasani Sadi F; Hashemi M; Tabari T; Rashidi M; Mirzaei S; Zarepour A; Zarrabi A; De Greef D; Bishayee A
Cell Mol Life Sci; 2022 Oct; 79(11):539. PubMed ID: 36194371
[TBL] [Abstract][Full Text] [Related]
35. Polyphenols as Lung Cancer Chemopreventive Agents by Targeting microRNAs.
Li J; Zhong X; Zhao Y; Shen J; Pilapong C; Xiao Z
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144639
[TBL] [Abstract][Full Text] [Related]
36. Use of curcumin-modified diamond nanoparticles in cellular imaging and the distinct ratiometric detection of Mg
Du BW; Tien LT; Lin CC; Ko FH
Nanoscale Adv; 2021 Jul; 3(15):4459-4470. PubMed ID: 36133469
[TBL] [Abstract][Full Text] [Related]
37. How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions.
Hussain Y; Khan H; Alotaibi G; Khan F; Alam W; Aschner M; Jeandet P; Saso L
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807304
[TBL] [Abstract][Full Text] [Related]
38. Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems.
Pinto B; Novais P; Henriques AC; Carvalho-Tavares J; Silva PMA; Bousbaa H
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745782
[TBL] [Abstract][Full Text] [Related]
39. Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules.
Costantino M; Corno C; Colombo D; Perego P
Front Pharmacol; 2022; 13():889816. PubMed ID: 35685638
[TBL] [Abstract][Full Text] [Related]
40. Molecular Mechanisms Involving the Sonic Hedgehog Pathway in Lung Cancer Therapy: Recent Advances.
Ma C; Hu K; Ullah I; Zheng QK; Zhang N; Sun ZG
Front Oncol; 2022; 12():729088. PubMed ID: 35433472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
